EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2

Published:2012-11 Issue:10 Volume:32 Page:2001-2005
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Narayanan Raja,Chhablani Jay,Sinha Manish,Dave Vivek,Tyagi Mudit,Pappuru Rajeev R.,Kuppermann Baruch D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference19 articles.

1. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.;Gass;Ophthalmology,1993

2. . Idiopathic macular telangiectasia.;Yannuzzi;Arch Ophthalmol,2006

3. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.;Park;Ophthalmology,1997

4. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.;Potter;Am J Ophthalmol,2002

5. . Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis.;Snyers;Am J Ophthalmol,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FROM OUTER RETINAL NEOVACULARIZATION TO EXUDATIVE SUBRETINAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2;Retina;2024-02-29

2. Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2;Cureus;2023-06-16

3. Makuläre Teleangiektasien Typ 2;Springer Reference Medizin;2023

4. Macular Telangiectasia Type 2: A Comprehensive Review;Clinical Ophthalmology;2022-10

5. Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization;Turkish Journal of Ophthalmology;2022-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3